EPIM
NVO

Echo Point Investment Management’s Novo Nordisk NVO Stock Holding History

Echo Point Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$2K Hold
110
– – 0.01% 16
2013
Q2 		$2K Buy
+110
New +$1.83K 0.01% 11

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SF
Sarofim Fayez Houston, Texas $20.5B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Echo Point Investment Management's NVO Position: Q3 2013 in Review

Echo Point Investment Management held its Novo Nordisk (NVO) position steady in Q3 2013 at 110 shares worth $2K. The position accounts for 0.01% of the portfolio, ranked #16.

Echo Point Investment Management first reported a position in NVO in Q2 2013 and has held it in 2 quarters since. 425 funds tracked by Wall St. Rank hold NVO as of Q3 2013.

  • Echo Point Investment Management held 110 shares of Novo Nordisk worth $2K as of Q3 2013.
  • Echo Point Investment Management left its Novo Nordisk share count unchanged in Q3 2013.
  • Novo Nordisk made up 0.01% of Echo Point Investment Management's portfolio in Q3 2013, its #16 holding.
  • Echo Point Investment Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 2 quarters since.
  • 425 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2013.

Based on Echo Point Investment Management's 13F filing for Q3 2013, filed 5 Nov 2013.